文献速递结核与非结核分枝杆菌

喀麦隆门诊及主动筛查中舌拭子与痰拭子TB检测性能

Diagnostic Performance of the Pluslife MiniDock MTB and Molbio MTB Ultima Assays to Detect Tuberculosis From Tongue and Sputum Swabs Among Outpatients and in Active Case Finding in Cameroon.
PubMed 文献 · Clin Infect Dis · 2026-01-01

在喀麦隆社区和医疗机构连续纳入1097名≥15岁个体,评估Pluslife MiniDock MTB和Molbio MTB Ultima对舌拭子和痰拭子检测结核的诊断准确性,以培养为参考标准。两种检测对痰和舌拭子的敏感性接近近即时检测的目标产品概况阈值,但涂片阴性结核的敏感性较低,需进一步在不同人群中验证。

要点

  • MiniDock MTB对痰和舌拭子敏感性分别为86%和76%,涂片阴性时降至67%和44%。
  • MTB Ultima对痰和舌拭子敏感性分别为84%和74%,涂片阴性时降至58%和33%。
  • 两种拭子检测性能接近近即时检测目标产品概况阈值,但涂片阴性敏感性不足。

核心结论

  • MiniDock MTB和MTB Ultima在舌拭子和痰拭子上的性能接近近即时检测结核试验的目标产品概况阈值。

研究设计与样本

  • 前瞻性诊断准确性研究,在喀麦隆社区(382人)和卫生机构(715人)连续纳入1097名15岁及以上参与者。
  • 以培养为参考标准,比较显微镜检查和Xpert MTB/RIF Ultra,评估MiniDock MTB和MTB Ultima对舌拭子和痰拭子的检测性能。

主要发现

  • 在132例培养阳性结核患者中,MiniDock MTB对痰和舌拭子的敏感性分别为86%(95%CI 79-91)和76%(95%CI 68-82)。
  • MiniDock MTB在涂片阴性结核患者中对痰和舌拭子的敏感性分别为67%(95%CI 51-79)和44%(29-59)。
  • MTB Ultima对痰和舌拭子的敏感性分别为84%(97/116;95%CI 76-89)和74%(67/91;95%CI 64-82)。
  • MTB Ultima在涂片阴性结核患者中对痰和舌拭子的敏感性分别为58%(95%CI 41-74)和33%(95%CI 18-53)。

临床怎么用

  • 两种检测在舌拭子和痰拭子上均表现出接近近即时检测阈值的敏感性,但涂片阴性结核的敏感性较低。
  • 研究结果支持在门诊和主动筛查场景中进一步评估这些拭子检测的可行性。

局限性

  • 研究仅在一个国家(喀麦隆)进行,需在不同人群和环境中进一步验证性能。
  • 原文未报告特异性、舌拭子自采与医护采集的比较结果等详细信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cost and infrastructure requirements limit access to current rapid molecular diagnostic testing for tuberculosis (TB). Recent developments in novel, swab-based assays that can be used closer to the point of care offer the potential to change the TB diagnostic landscape. METHODS: We assessed the diagnostic accuracy of 2 tests, Molbio Truenat MTB Ultima (MTB Ultima) and Pluslife MiniDock MTB Test (MiniDock MTB), among consecutively enrolled individuals aged 15 years and older, against the reference standard of culture and comparators of microscopy and Xpert MTB/RIF Ultra. Two tongue swabs, either self-collected or healthcare worker collected, and 2 sputum specimens were requested from each participant; MiniDock MTB was tested the same day and MTB Ultima was tested after storage. RESULTS: From February to June 2025, 1097 participants were enrolled in communities (382) and at health facilities (715). Sensitivities of sputum and tongue swabs on MiniDock MTB among 132 people with culture-positive TB were 86% (95% confidence interval [CI], 79-91) and 76% (95% CI, 68-82), respectively, and 67% (95% CI, 51-79) and 44% (29-59) among those with smear-negative TB. Sensitivities of sputum and tongue swabs on MTB Ultima were 84% (97/116; 95% CI, 76-89) and 74% (67/91; 95% CI, 64-82), respectively, and 58% (95% CI, 41-74) and 33% (95% CI, 18-53) among those with smear-negative TB. CONCLUSIONS: In this population, the performance of both MiniDock MTB and MTB Ultima on tongue and sputum swabs was similar to target product profile thresholds for near point-of-care TB tests. Further studies to evaluate performance in diverse populations and settings are needed.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mbuli C, Taya-Fokou JB, Nsamenang R, et al. Diagnostic Performance of the Pluslife MiniDock MTB and Molbio MTB Ultima Assays to Detect Tuberculosis From Tongue and Sputum Swabs Among Outpatients and in Active Case Finding in Cameroon. Clin Infect Dis. 2026. PMID: 41432010. doi:10.1093/cid/ciaf709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。